Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
AssigneeMicrobion Corporation
InventorsBrett Hugh James Baker, Philip Domenico
Life of this patent
Estimating the term…
Loading patent…
AssigneeMicrobion Corporation
InventorsBrett Hugh James Baker, Philip Domenico
Estimating the term…
Compositions and methods, including novel homogeneous microparticulate suspensions, are described for treating acute wounds, chronic wounds and/or a wound or epithelial tissue surface that contains bacterial biofilm, including unexpected synergy between bismuth-thiol (BT) compounds and certain antibiotics, to provide topical formulations including antiseptic formulations, for management and promotion of wound healing and in particular infected wounds. Previously unpredicted antibacterial properties and anti-biofilm properties of disclosed BT compounds and BT compound-plus-antibiotic combinations are also described, including preferential efficacies of certain such compositions for treating gram-positive bacterial infections, and distinct preferential efficacies of certain such compositions for treating gram-negative bacterial infections.
A bismuth-thiol (BT) composition, comprising a plurality of solid microparticles and a pharmaceutically acceptable carrier, wherein substantially all of said microparticles having a volumetric mean diameter (VMD) of from about 0.4 μm to about 5 μm, said microparticles comprising a BT compound comprising bismuth and/or a bismuth salt, and wherein the composition does not include a liposome.
Dependencies are inferred from the claim text.